India News: The number of people infected with the coronavirus in England fell by almost half over the past month marking the lowest level of Covid-19 cases since
and Variant Neutralization Results In April 2021, Ocugen announced that its co-development partner, Bharat Biotech International Limited ( Bharat Biotech ), shared positive results from the second interim analysis of its Phase 3 clinical trial of COVAXIN showing 78% overall efficacy against COVID-19 disease, 100% efficacy against severe COVID-19 disease (including hospitalization), and 70% efficacy against asymptomatic COVID-19 infection, indicating the potential to significantly reduce virus transmission. COVAXIN has additionally demonstrated a remarkable safety profile with several million doses administered to date in India. Moreover, in-vitro studies conducted by the Indian Council of Medical Research-National Institute of Virology have provided data suggesting effectiveness in neutralizing the double mutant India variant, the U.K. variant, and the Brazil variant. Based on broad immunogenicity, Ocugen believes that COVAXIN has the potential to be effective against other emergi
May 2, 2021 • 4:02 pm CDT (Precision Vaccinations)
Scientists at the Indian Council of Medical Research-National Institute of Virology confirmed on April 30, 2021, they have found that the Covaxin COVID-19 vaccine is effective against the Brazil variant, B.1.128.2.
Published as a bioRxiv preprint, this new study shows that the two-dose regimen significantly boosted IgG antibody titer and neutralizing efficacy against the Brazil variant and D614G variant as compared to that seen with natural infection.
This study also demonstrated 1.92 and 1.09 fold reductions in the neutralizing titer against B.1.1.28.2 variant compared to prototype D614G variant with sera of vaccine recipients and natural infection, respectively.
Is the Kent Covid variant fuelling India s explosion in infections? Cases of mutant strain in Kerala region have risen 10-FOLD in a month and now make up a THIRD of all samples… and it is linked to 90% of positives in northern states
Kent Covid variant already dominant in the UK and US and it is in 130 countries
Indian reports show it accounts for surging proportion of infections there
It is known to be faster-spreading than other strains of the virus
Not much is known about the Indian variant but it doesn t appear to be worse
India is in a state of crisis with hospitals overwhelmed and thousands dying
Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
A new coronavirus vaccine candidate could soon be authorized for use, if its excellent clinical results are any indication.
Ocugen (NASDAQ:OCGN) has unveiled the results of a phase 3 clinical trial of the Covaxin vaccine conducted by its co-development partner Bharat Biotech. Most notably, the vaccine demonstrated 100% efficacy against severe COVID-19.